Transgene

Transgene is a clinical-stage biotechnology company dedicated to designing and developing innovative immunotherapies against cancer. Their mission is to create novel treatments that utilize the body's own immune system to fight the disease, focusing on both therapeutic vaccines and oncolytic viruses. The company boasts a strong team of over 160 employees, with a significant emphasis on research and development, representing 72% of their staff. Transgene is a pioneer in viral vector engineering and has a strong commitment to ethical business practices and data protection.

Transgene's portfolio includes several clinical-stage products, demonstrating their commitment to translating research into tangible therapies. Their therapeutic vaccines include TG4001, targeting HPV-induced cancers, and TG4050, an individualized neoantigen vaccine for head and neck cancers. Transgene also develops oncolytic viruses, such as BT-001, armed with an anti-CTLA4 antibody and GM-CSF, for treatment of solid tumors, and TG6050, expressing IL-12 and an anti-CTLA4 antibody, for non-small cell lung cancer. Through their two platforms, myvac® and Invir.IO®, Transgene aims to push the boundaries of immunotherapy and bring effective treatments to patients with cancer.

Transgene is a clinical-stage biotechnology company committed to developing innovative immunotherapies to combat cancer. The company utilizes cutting-edge technology, a multidisciplinary team, and a prestigious international network to push the boundaries of immunotherapy, ultimately aiming to create innovative treatments that leverage the body's natural immune system to fight disease.

Transgene fosters a collaborative, entrepreneurial culture that values excellence, responsibility, initiative, and teamwork. They prioritize professional development by encouraging employees to participate in international conferences, collaborate with the scientific and medical community, and engage in continuous learning. They also promote a culture of inclusion and diversity, striving for equal treatment and non-discrimination in their workforce.

Transgene is committed to fostering a diverse, equitable, and inclusive workplace. The company actively promotes equal opportunities for all employees, regardless of their background, and strives to create an environment where everyone feels valued, respected, and empowered. Transgene also prioritizes the integration and retention of disabled workers, upholding principles of equality and non-discrimination in all its operations.